UBS AM
UTMD icon

UBS AM’s Utah Medical Products UTMD Stock Holding History

UBS AM’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.1K Hold
393
– – ﹤0.01% 3065
2026
Q1 		$24.4K Buy
393
+297
+309% +$18.7K ﹤0.01% 3097
2025
Q4 		$5.37K Buy
+96
New +$5.57K ﹤0.01% 2968
2022
Q3 		– Sell
-44
Closed -$3.78K – 2777
2022
Q2 		$3.78K Buy
+44
New +$3.75K ﹤0.01% 2682

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS AM's UTMD Position: Q2 2026 in Review

UBS AM held its Utah Medical Products (UTMD) position steady in Q2 2026 at 393 shares worth $27.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3065.

UBS AM first reported a position in UTMD in Q2 2022 and has held it in 4 quarters since. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • UBS AM held 393 shares of Utah Medical Products worth $27.1K as of Q2 2026.
  • UBS AM left its Utah Medical Products share count unchanged in Q2 2026.
  • Utah Medical Products made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3065 holding.
  • UBS AM first reported a position in Utah Medical Products in Q2 2022 and has held it in 4 quarters since.
  • 114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.